Dyschromatosis symmetrica hereditaria
MONDO:0007483Acropigmentation of Dohi is a genodermatosis characterized by the presence of hyperpigmented and hypopigmented macules, principally located on the extremities and limbs.
Also known as: DSH1, RAD, acropigmentation of Dohi, dyschromatosis symmetrica hereditaria, reticulate acropigmentation of Dohi, DSH, dyschromatosis symmetrica hereditaria 1, familial reticulate acropigmentation of Dohi
15 clinical trials for this condition and its sub-types, 1 tagged with Dyschromatosis symmetrica hereditaria itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New pill aims to tame rare immune diseases
Disease control OngoingThis early-stage trial tests an experimental drug called BI 3000202 in 16 adults with rare type 1 interferonopathies, such as Aicardi-Goutières syndrome. Participants take a low dose for 4 weeks, then a higher dose for 36 weeks. The main goal is to see if the drug is safe and how…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a Drug-Radiation combo outsmart Treatment-Resistant colorectal cancer?
Disease control CancelledThis phase 2 trial is testing whether combining an experimental drug called S-531011 with a precise radiation technique known as RadScopal can help control metastatic colorectal cancer that has not responded to prior treatments. The study enrolls about 30 adults with advanced dis…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC